The Gastroenterology Channel

Updates from ESMO 2022 in Colorectal Cancer

Chetan Deshmukh, MBBS, a medical oncologist from Deenanath Mangeshkar Hospital and Research Center, Pune, India, discusses the CAIRO5 study, which was presented at the congress, and shares his thoughts on novel immunotherapeutics and targeted therapies for the management of colorectal cancer. Dr Deshmukh also comments on how patients can gain access to novel treatments in global clinical trials and he provides thoughts on drug access disparities in low- and middle-income countries.

More in Gastroenterology

► 02:43

Breakthrough Innovations: Mayo Clinic’s Gastroenterology & Hepatology Experts

Gastroenterology

In this video, specialists from the Mayo Clinic discuss the revolutionary strides in gastroenterology facilitated by technological advancements, enhancing patient care significantly. They emphasize Mayo Clinic's unique integrated approach, which...

► 55:20

Screening for Barrett’s Esophagus

Gastroenterology

Jennifer M. Kolb, MD, MS, assistant professor of medicine, David Geffen School of Medicine, UCLA, discusses the rationale for and limitations to screening for Barrett's esophagus and esophageal cancer. Dr...

► 4:57

Patient Journeys: Diagnosis and Treatment of Esophageal Cancer

Gastroenterology

Nikhil Agarwal, MD, director of gastrointestinal oncology, Max Super Speciality Hospital, Saket, India, discusses the journey a patient with esophageal cancer experiences after diagnosis. Dr Agarwal also reviews the causes,...

► 58:25

Management of Ogilvie’s Syndrome

Gastroenterology

Jennifer Jo, MD, gastroenterology fellow, Icahn School of Medicine at Mount Sinai, discusses current guidelines for management of Ogilvie's syndrome. Dr Jo also reviewed medical, endoscopic, and surgical options. Dr...